GLP-1-Based Therapies: The Dilemma of Uncertainty

被引：37

作者：

Spranger, Joachim ^{[1
,2
]}

Gundert-Remy, Ursula ^{[2
]}

Stammschulte, Thomas ^{[2
]}

机构：

[1] Charite, Dept Endocrinol Diabet & Nutr, D-13353 Berlin, Germany

[2] German Med Assoc, Drug Commiss, Berlin, Germany

来源：

GASTROENTEROLOGY | 2011年 / 141卷 / 01期

关键词：

ACUTE-PANCREATITIS; EXENATIDE; SITAGLIPTIN; MINIREVIEW; RISK;

D O I：

10.1053/j.gastro.2011.05.019

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：20 / 23

页数：5

共 20 条

[1] Association of Pancreatitis with Glucagon-Like Peptide-I Agonist Use [J].

Anderson, Sarah L. ;

Trujillo, Jennifer M. .

ANNALS OF PHARMACOTHERAPY, 2010, 44 (05) :904-909

[2]

[Anonymous], SCI DISCUSSION

[3]

[Anonymous], VICTOZA LIRAGLUTIDE

[4]

Arzneimittelkommission der Deutschen arzteschaft (Drug Commission of the German Medical Association), 2011, DTSCH ARZTEBL, V108, pA

[5] Minireview: Update on Incretin Biology: Focus on Glucagon-Like Peptide-1 [J].

Brubaker, Patricia L. .

ENDOCRINOLOGY, 2010, 151 (05) :1984-1989

[6] Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system [J].

Brubaker, PL ;

Drucker, DJ .

ENDOCRINOLOGY, 2004, 145 (06) :2653-2659

[7]

Cohen D, 2010, BMJ-BRIT MED J, V341, P530

[8]

Cure P, 2008, NEW ENGL J MED, V358, P1969, DOI 10.1056/NEJMc0707137

[9] Exenatide (Exendin-4)-induced pancreatitis - A case report [J].

Denker, PS ;

Dimarco, PE .

DIABETES CARE, 2006, 29 (02) :471-471

[10] A cohort study of acute pancreatitis in relation to exenatide use [J].

Dore, D. D. ;

Bloomgren, G. L. ;

Wenten, M. ;

Hoffman, C. ;

Clifford, C. R. ;

Quinn, S. G. ;

Braun, D. K. ;

Noel, R. A. ;

Seeger, J. D. .

DIABETES OBESITY & METABOLISM, 2011, 13 (06) :559-566

← 1 2 →